x.com/MazurKrzysztof/status/2112222876786962654

Eurostat’s 2025 high-tech trade release does support a large EU surplus with the United States overall in high-tech goods, but it does not support the claim that this surplus was mainly due to aviation and space products alongside pharmaceuticals.

According to Eurostat:

• EU high-tech exports to the US in 2025 were €195.1 billion.
• EU high-tech imports from the US in 2025 were €131.4 billion.
• Of exports to the US, 62% were pharmaceuticals and 12% were aerospace products.
• Of imports from the US, 36% were aerospace products and 33% were pharmaceuticals.

That means, using Eurostat’s published shares:

• Pharmaceuticals: about €121.0bn exported vs €43.4bn imported → a large surplus.
• Aerospace: about €23.4bn exported vs €47.3bn imported → a large deficit.

So pharmaceuticals clearly contributed to the surplus, but aerospace/aviation-space products did the opposite: they were a net negative, not a main reason for the surplus.

Even allowing for Eurostat’s category shares to be rounded to whole percentages, the conclusion does not change. With 12% of €195.1bn versus 36% of €131.4bn, aerospace imports from the US are far above aerospace exports to the US, so aerospace cannot plausibly be one of the main sources of the surplus.